Sign Up to like & get
recommendations!
0
Published in 2020 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2020.106163
Abstract: OBJECTIVES Drug-resistance represents a major threat in the fight against tuberculosis. Globally, isoniazid-monoresistant tuberculosis (Hr-TB) is twice as common as multidrug/rifampicin-resistant (MDR/RR)-TB. Recently updated WHO guidelines now recommend treatment of Hr-TB with rifampicin, ethambutol, pyrazinamide…
read more here.
Keywords:
retrospective case;
case series;
monoresistant tuberculosis;
isoniazid monoresistant ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Saudi medical journal"
DOI: 10.15537/smj.2021.42.6.20200832
Abstract: OBJECTIVES To determine the prevalence and outcome in patients with isoniazid-monoresistant Mycobacterium tuberculosis complex and compare them to those in patients with non-isoniazid-monoresistant Mycobacterium tuberculosis. METHODS This cross-sectional analytical study was conducted at King Khalid…
read more here.
Keywords:
isoniazid;
outcome;
prevalence;
monoresistant tuberculosis ... See more keywords